PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 1 St. Kiriakidi Street, 54636, Thessaloníki, Greece.\', \'Cardiology Department, St.Thomas\' Hospital, London, UK.\', \'Infectious Diseases Division, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloníki, Greece.\', \'Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, 1 St. Kiriakidi Street, 54636, Thessaloníki, Greece. kalmanthou@yahoo.gr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11096-021-01256-9
?:doi
?:hasPublicationType
?:journal
  • International journal of clinical pharmacy
is ?:pmid of
?:pmid
?:pmid
  • 33751323
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.702
?:rankingScore_hIndex
  • 51
?:title
  • Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33751323>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33751323>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all